One new requirement under the Cures Act is for manufacturers of an investigational drug to make its policies on evaluating and responding to compassionate use requests publicly available.
Pat Roberts: “One new requirement under the Cures Act is for manufacturers of an investigational drug to make its policies on…”
Editor's note · Context
Senator Roberts discusses a new requirement for drug manufacturers under the Cures Act.
Share
More from Pat Roberts
Whatever we can do to open up even more the use of telehealth services to support the local rural health-care professionals.
It is an honor to be here today in support of my Kansas friend and colleague Mike Pompeo as the President's nominee for Secretary of State.
I strongly agree with USTR's assessment that we have significant problems related to intellectual property and other market access-related issues with China.
But short-term, for goodness' sake, do not, in this business of playing your cards of trying to get a better deal for the United States or a better trade situation, do not do so at the expense of American agriculture, which is going…





